• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Fat Tail Daily

Investment Ideas From the Edge of the Bell Curve

  • Menu
    • Commodities
      • Resources and Mining
      • Copper
      • Gold
      • Iron Ore
      • Lithium
      • Silver
      • Graphite
      • Rare Earths
    • Technology
      • AI
      • Bitcoin
      • Cryptocurrency
      • Energy
      • Financial Technology
      • Bio Technology
    • Market Analysis
      • Latest ASX News
      • Dividend Shares
      • ETFs
      • Stocks and Bonds
    • Macro
      • Australian Economy
      • Central Banks
      • World Markets
    • Small Caps
    • More
      • Investment Guides
      • Premium Research
      • Editors
      • About
      • Contact Us
  • Latest
  • Fat Tail Series
  • About Us
Market Analysis Latest ASX News

Avita Medical Share Price Hovering Below 50 Cents (ASX:AVH)

Like 0

By Carl Wittkopp, Tuesday, 28 April 2020

With the Avita Medical Ltd (ASX:AVH) share price sitting at 45 cents at time of writing, let’s take a quick look at this stock that lit up the ASX prior to the onset of the coronavirus. Avita recently announced a plan to relocate from Australia to the United States...

With the Avita Medical Ltd [ASX:AVH] share price sitting at 45 cents at time of writing, let’s take a quick look at this stock that lit up the ASX prior to the onset of the coronavirus.

Avita recently announced a plan to relocate from Australia to the United States. This was done with the view that the advantages of the move will outweigh its disadvantages and risks.

Noted in the announcement, the board believes the move will:

‘Substantially reduce the costs, burden, resourcing, and risks associated with dual financial reporting and related compliance obligations that the Company has become subject to in both the United States and Australia (since 31 December 2019).’

This is expected to save approximately AU$400,000 per annum in external professional costs alone.

The regenerative medicine company with a market cap of $906.71 million, at the time of writing, appears to be taking this bold step so in the future they can align themselves with a broader range of capital investors in the US.

In many ways, it makes sense.

In terms of cumulative market cap, the NASDAQ is massive compared to Australia’s ASX and many Aussie companies working in the healthcare sector seek to crack this lucrative market.

Avita share price: the present

Avita makes and sells the product RECELL®, which is a spray on system designed to treat burn victims.

Avita’s foothold is in the US, with it being noted in recent announcements that Avita ‘derives virtually all its revenue from the US’ and has no physical presence outside of the country.

You can see the weekly chart for the Avita share price below:

ASX AVH - Avita Share Price Chart 1

Source: Optuma

Avita share price: the future

On a technical basis, Avita had a pull back in share price over two weeks, falling back just under 61.8% of the previous range, a strong level in the Fibonacci scale. This falls in between two historical support and resistance levels of 33 cents and 54 cents.

ASX AVH - Avita Share Price Chart 2

Source: Optuma

The current bar on the weekly chart holds a close higher than the open, indicating a move up, yet this was not supported by volume. From this it may be assumed the share price could continue to fall, in that case support level of 33 cents may come into focus.

Should price return to the upside, resistance levels of 45 cents, 52 cents, and 58 cents may come into play.

ASX AVH - Avita Share Price Chart 3

Source: Optuma

The next few weeks may be a very interesting time to watch Avita, it could cut in two directions quickly.

Stinging from the AVH share price drop? If you want to learn about the two types of assets that could benefit from this new investing environment, download a free copy of ‘The Coronavirus Portfolio’. In it, my colleague Lachlann Tierney runs you through the kinds of investments he thinks have the most potential in the downturn.

Regards,

Carl Wittkopp,
For Money Morning

All advice is general advice and has not taken into account your personal circumstances.

Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

Comments

Subscribe
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments
Carl Wittkopp

Carl’s Premium Subscriptions

Publication logo
Fat Tail Investment Research

Latest Articles

  • America on a War Footing: Implications as US Mineral Strategy Turns to Africa
    By James Cooper

    Geologist James Cooper examines the potential implications of America’s heavy focus on West Africa. Why is the US becoming deeply involved here? And what could the consequences be?

  • The biggest quarter on record for this share
    By Callum Newman

    We can see why the stock market didn’t react much to the RBA holding rates steady last meeting. Everyone expects rates to go down. It’s just a question of when. Fixed rate loans, and refinancings, are withering away as the market positions for more rate cuts. This is what you and I want to see as investors…

  • The US$2 Trillion Stablecoin Tsunami
    By Charlie Ormond

    These developments could transform the US$250 billion stablecoin market into a US$2 trillion juggernaut within years.

Primary Sidebar

Latest Articles

  • America on a War Footing: Implications as US Mineral Strategy Turns to Africa
  • The biggest quarter on record for this share
  • The US$2 Trillion Stablecoin Tsunami
  • Trump Sparks Rare Earth Rally
  • Copper Breaks Out: Are You Positioned?

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2025 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988